30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
France Biotechnology & Medical Research

Oncodesign Precision Medicine Opm SA (ALOPM)

Track

Stock chart
Ticker: ALOPM Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Philippe GENNE
Président Directeur-Général
1 sale — total 164,000 EUR
Sale 12 Dec 2022
Value €832,043.92 | Price 223.62 | Shares 70,631
Through SAS P.C.G Société par actions simplifiée, a closely affiliated person
Buy 12 Dec 2022
Value €2,615,701.34 | Price 356.46 | Shares 59,994
Sale 8 Dec 2022
Value €123,000.00 | Price 0.82 | Shares 150,000
Through SAS P.C.G Société par actions simplifiée, a closely affiliated person
Buy 8 Dec 2022
Value €123,000.00 | Price 0.82 | Shares 150,000
Buy 28 Oct 2022
Value €117,115.60 | Price 0.70 | Shares 167,308
Through P.C.G. société civile, a closely affiliated person
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-19 2022-12-12 S Sale
Philippe GENNE

Président Directeur-Général

Through SAS P.C.G Société par actions simplifiée, a closely affiliated person Executive Director
70,631
223.62
€832,044 		70,631 223.62 €832,044
2022-12-19 2022-12-12 B Purchase
Karine LIGNEL

Administratrice

Director
59,994
356.46
€2,615,701 		59,994 356.46 €2,615,701
2022-12-19 2022-12-08 S Sale
Philippe GENNE

Président Directeur-Général

Through SAS P.C.G Société par actions simplifiée, a closely affiliated person Executive Director
25,855
74.73
€3,841,678 		25,855 74.73 €3,841,678
2022-12-19 2022-12-08 B Purchase
Jan HOFLACK

Administrateur

Director
150,000
0.82
€123,000 		150,000 0.82 €123,000
2022-12-08 2022-10-28 B Purchase
PHILIPPE GENNE

PRESIDENT DIRECTEUR GENERAL

Through P.C.G. société civile, a closely affiliated person Executive Director
167,308
0.70
€117,116 		167,308 0.70 €117,116
Explore more

More insider trading research around Oncodesign Precision Medicine Opm SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe